The Economics of Shared Care Packages Sarah M. McGheeAnthony J. Hedley Leading Article 03 December 2012 Pages: 197 - 204
Interferon-α in Hepatitis C Andrew BriggsAlan Shiell Leading Article 03 December 2012 Pages: 205 - 209
An Historical Survey of UK Government Measures to Control the NHS Medicines Expenditure from 1948 to 1996 John P. Griffin Review Article 03 December 2012 Pages: 210 - 224
Economic Implications of Resistance to Antimalarial Drugs Margaret PhillipsPenelope A. Phillips-Howard Review Article 03 December 2012 Pages: 225 - 238
Cost Saving of 5-day Therapy with Cefpodoxime Proxetil versus Standard 10-day β-Lactam Therapy for Recurrent Pharyngotonsillitis in Adults Alain PelcHenri PortierFrançoise Ichou Original Research Article 29 November 2012 Pages: 239 - 250
Dynamic Competition as an Exploratory Model of Healthcare Policy for the Antihypertensive Market Robert J. BonkMaven J. MyersWilliam F. McGhan Original Research Article 03 December 2012 Pages: 251 - 261
A Comparison of the Cost Effectiveness of Alternative Prophylactic Therapies in Childhood Asthma Philip C. BoothNicholas E. J. WellsAlan K. Morrison Original Research Article 03 December 2012 Pages: 262 - 268
Impact of Selective Financing of Drugs on Pharmaceutical Expenditure Control in the Province of Valladolid, Spain Maria A. de MarinoJose M. MarquésAlfonso Velasco Original Research Article 03 December 2012 Pages: 269 - 280
Streptokinase Jane C. GillisKaren L. Goa Pharmacoeconomic Drug Evaluation 03 December 2012 Pages: 281 - 310
Glossary of Terms Used in Health Economics and Pharmacoeconomics and Quality-of-Life Analyses Glossary 03 December 2012 Pages: 311 - 314